# Tirzepatide Impact Assessment Study

> **NCT07740291** · NA · RECRUITING · sponsor: **Texas Tech University** · enrollment: 27 (estimated)

## Conditions studied

- Obesity & Overweight
- Cardiometabolic Health Indicators
- Addiction
- Eating Disorders
- Mental Health

## Interventions

- **DRUG:** GLP-1 Receptor Agonist Therapy
- **BEHAVIORAL:** Structured Lifestyle Intervention

## Key facts

- **NCT ID:** NCT07740291
- **Lead sponsor:** Texas Tech University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-02
- **Primary completion:** 2026-11-23
- **Final completion:** 2026-12-07
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07740291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07740291, "Tirzepatide Impact Assessment Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07740291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*